319
Participants
Start Date
June 30, 2010
Primary Completion Date
November 30, 2011
Study Completion Date
November 30, 2011
TC-5214
Tablet, oral, twice daily for 8 weeks
Placebo
Tablet, oral, twice daily for 8 weeks
Research Site, Tuscaloosa
Research Site, Tucson
Research Site, Little Rock
Research Site, Chino
Research Site, Costa Mesa
Research Site, Encino
Research Site, Escondido
Research Site, Los Alamitos
Research Site, Oceanside
Research Site, Pico Rivera
Research Site, San Diego
Research Site, Torrance
Research Site, Hamden
Research Site, Coral Springs
Research Site, Jacksonville
Research Site, Orange City
Research Site, Orlando
Research Site, Tampa
Research Site, Chicago
Research Site, Prairie Village
Research Site, Florence
Research Site, Shreveport
Research Site, St Louis
Research Site, New York
Research Site, Rochester
Research Site, Staten Island
Research Site, Cincinnati
Research Site, Dayton
Research Site, Middleburg Heights
Research Site, Portland
Research Site, Salem
Research Site, Norristown
Research Site, Charleston
Research Site, Dallas
Research Site, Houston
Research Site, Woodstock
Research Site, Seattle
Research Site, Visakhapatnam
Research Site, Guntur
Research Site, Ahmedabad
Research Site, Rajkot
Research Site, Mangalore
Research Site, Aurangabad
Research Site, Pune
Research Site, Nashik
Research Site, Jaipur
Research Site, Khātīpura
Research Site, Madurai
Research Site, Varanasi
Research Site, Kanpur
Research Site, Mysore
Lead Sponsor
Targacept Inc.
INDUSTRY
AstraZeneca
INDUSTRY